Literature DB >> 6665702

Facilitating patient compliance in glaucoma therapy.

T J Zimmerman, A H Zalta.   

Abstract

Noncompliance is a major problem in glaucoma therapy. The causes, forms, and sociological variables associated with noncompliance are reviewed. A comprehensive strategy to facilitate the safe and effective use of glaucoma medications is presented and discussed. This strategy combines education about the disease and its treatment, "tailoring" of the therapeutic regimen, training and reinforcement in eyedrop application, cooperation with primary care physicians, alleviating side effects, and improving doctor-patient relationships.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6665702     DOI: 10.1016/0039-6257(83)90142-x

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  18 in total

1.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

Review 2.  Topical medication instillation techniques for glaucoma.

Authors:  Li Xu; Xuemei Wang; Meijing Wu
Journal:  Cochrane Database Syst Rev       Date:  2017-02-20

3.  Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.

Authors:  Jack Stringham; Noy Ashkenazy; Anat Galor; Sarah R Wellik
Journal:  Eye Contact Lens       Date:  2018-01       Impact factor: 2.018

4.  Patient acceptance to smartphone technology to monitor and improve glaucoma health-care outcomes.

Authors:  R M H Lee; J D Oleszczuk; J N Hyer; G Gazzard
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

5.  A study of the causes of non-compliance by patients prescribed eyedrops.

Authors:  A J Winfield; D Jessiman; A Williams; L Esakowitz
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

6.  Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.

Authors:  A L Robin; R Ritch; D Shin; B Smythe; T Mundorf; R P Lehmann
Journal:  Trans Am Ophthalmol Soc       Date:  1995

Review 7.  Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.

Authors:  David C Broadway; Heidi Cate
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

8.  Drug attitude and adherence to anti-glaucoma medication.

Authors:  Samin Hong; Sung Yong Kang; Jong Uk Yoon; Uicheon Kang; Gong Je Seong; Chan Yun Kim
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

9.  The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  An evaluation of how glaucoma patients use topical medications: a pilot study.

Authors:  Tony Tsai; Alan L Robin; Judson P Smith
Journal:  Trans Am Ophthalmol Soc       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.